Xylem Inc. Q2 FY26 Earnings Analysis

Published 29 May 2026 | Machinery | Market Cap: ₹26.0K Cr

Price

109.25

Market Cap

₹26.0K Cr

P/E Ratio

27.6

Revenue Rank

Rank 4

Margin Rank

Rank 3

Earnings Summary

- Full-year reported revenue guidance raised to $9.2 billion to $9.3 billion, reflecting 2%-3% growth. - Organic revenue growth forecast remains 2%-4%, unchanged from prior guidance. - Expectation of sequential volume growth ramp in second half of 2026, particularly from water infrastructure. - MCS segment expects double-digit order growth in water throughout the remainder of the year. - Strong backlog at $4.7 billion supports future revenue. - Anticipated mid-single-digit organic revenue growth in Applied Water and Water Infrastructure segments for the full year. - Capital project timing impacts near-term revenue, especially in Water Solutions and Services. - Long-term order growth for MCS expected at high-single-digit annual rates over a rolling 24-month period. - Market recovery expected, with China bottoming out and utility demand remaining resilient, especially in the U.S. - Guidance for full-year EPS remains unchanged at $5.35 to $5.60, reflecting a prudent approach amid macro uncertainties (Page 3).

📊 Revenue & Sales Performance

Rank 4

- Full-year reported revenue guidance raised to $9.2 billion to $9.3 billion, reflecting 2%-3% growth. - Organic revenue growth forecast remains 2%-4%, unchanged from prior guidance. - Expectation of sequential volume growth ramp in second half of 2026, particularly from water infrastructure. - MCS segment expects double-digit order growth in water throughout the remainder of the year. - Strong backlog at $4.7 billion supports future revenue. - Anticipated mid-single-digit organic revenue growth in Applied Water and Water Infrastructure segments for the full year. - Capital project timing impacts near-term revenue, especially in Water Solutions and Services. - Long-term order growth for MCS expected at high-single-digit annual rates over a rolling 24-month period. - Market recovery expected, with China bottoming out and utility demand remaining resilient, especially in the U.S. and India.

📈 Profitability & Margins

Rank 3

- Guidance for full-year EPS remains unchanged at $5.35 to $5.60, reflecting a prudent approach amid macro uncertainties (Page 3). - Targeting mid-teens EPS growth supported by $1 billion annual capital deployment through disciplined M&A (Page 6). - Margin expansion expected, driven by price realization, productivity, and volume growth, especially in the second half of 2026 (Page 8). - MCS segment expected to exit 2026 with EBITDA margin well above 25%, providing a strong base for 2027 (Page 8). - Organic revenue growth guide of 2% to 4% confirmed, with volume and mix normalization supporting margin improvement (Pages 3, 8). - Operational discipline and simplification efforts anticipated to drive margin expansion between 22.9% to 23.3% for full year 2026 (Page 3).

🏗️ Capital Expenditure Plans

Yes

- Xylem plans capital deployment of approximately $1 billion annually towards M&A to support mid-teens EPS growth, as reiterated by CFO William Grogan. - The recent acquisition of a German firm specializing in highly-engineered water quality instruments was completed for $219 million, strengthening Xylem’s position in optical sensing and process applications. - The acquisition is expected to generate significant revenue synergies by leveraging Xylem’s industrial and utility customer base. - The company continues to execute opportunistic share repurchases, having spent $581 million in Q1 under a new $1.5 billion authorization. - Capex was higher in Q1 but is part of planned investment towards growth and operational improvements. - The company balances capital deployment between M&A, share repurchases, and sustaining investment with a focus on maintaining leverage between 0.5x to 1x net debt to EBITDA. - Long-term capital allocation remains disciplined to support growth, cash flow generation, and maintaining a healthy balance sheet.

💰 Fundraising & Capital Structure

No information

- There is no explicit mention of new fundraising through debt or equity in the call transcript. - The company has a healthy balance sheet and is focused on managing leverage between half a turn and one turn net debt to EBITDA. - Capital allocation includes opportunistic share repurchases, with $581 million executed in Q1 and a new $1.5 billion share repurchase authorization announced in February. - The company plans to deploy capital across its framework throughout the year, including M&A targeting $1 billion annually. - No specific plans or discussions of raising new debt or equity were disclosed, indicating no immediate fundraising initiatives.

📋 Order Book & Pipeline

No

- Ending backlog (orderbook) up sequentially to $4.7 billion. - Book-to-bill for the quarter was above 1. - Orders were flat year-over-year, impacted by project timing in Water Solutions & Services (WSS), offset by strength in other segments. - In Measurement & Control Solutions (MCS), orders increased robustly by 15%, driven by smart metering demand in water. - Expect double-digit order growth for water in MCS throughout the balance of the year. - Backlog in MCS remained flat sequentially at roughly $1.4 billion. - Orders in Water Infrastructure up 2% in the quarter, driven by strong demand in transport (US and India). - WSS saw order decline driven by capital project timing, but subsequently booked largest ever order of $850 million with a 20-year outsourced water contract. - Overall, the pipeline for M&A is strong across all segments, supporting disciplined capital deployment.

Key Metrics

Revenue

Rank 4

Margin

Rank 3

Capex

Yes

Fundraise

No information

Order Book

No

Frequently Asked Questions

What were Xylem Inc. Q2 FY26 results?

- Full-year reported revenue guidance raised to $9.2 billion to $9.3 billion, reflecting 2%-3% growth. - Organic revenue growth forecast remains 2%-4%, unchanged from prior guidance. - Expectation of sequential volume growth ramp in second half of 2026, particularly from water infrastructure. - MCS segment expects double-digit order growth in water throughout the remainder of the year. - Strong backlog at $4.7 billion supports future revenue. - Anticipated mid-single-digit organic revenue growth in Applied Water and Water Infrastructure segments for the full year. - Capital project timing impacts near-term revenue, especially in Water Solutions and Services. - Long-term order growth for MCS expected at high-single-digit annual rates over a rolling 24-month period. - Market recovery expected, with China bottoming out and utility demand remaining resilient, especially in the U.S. - Guidance for full-year EPS remains unchanged at $5.35 to $5.60, reflecting a prudent approach amid macro uncertainties (Page 3).

What is Xylem Inc. share price analysis?

Xylem Inc. currently shows a neutral. The stock trades at a P/E of 27.6 with a market cap of $25,968. Investors should review the full earnings analysis for detailed insights.

Is Xylem Inc. planning capital expenditure?

- Xylem plans capital deployment of approximately $1 billion annually towards M&A to support mid-teens EPS growth, as reiterated by CFO William Grogan.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.